家家悦(603708.SH):非公開發行股票批覆到期失效
格隆匯3月2日丨家家悦(603708.SH)公佈,公司於2021年3月9日收到中國證券監督管理委員會核發的《關於核准家家悦集團股份有限公司非公開發行股票的批覆》(證監許可【2021】648號),核准公司非公開發行不超過18,252萬股新股,批覆自核準發行之日(2021年3月3日)起12個月內有效。
公司在取得批覆後一直積極推進本次非公開發行股票的發行事宜,但由於資本市場環境變化和發行時機等多方面原因,公司未能在批覆的有效期內實施本次非公開發行股票事宜,該批覆到期自動失效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.